Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 908
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +5.9%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.4 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (459)

clinicaltrialsPublishedShowing 51–100 of 257 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07179900	Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma	recruiting	Phase 2	60	Hebei Medical University Fourth HospitalOTHER	1	Aug 3, 2026	clinicaltrials
NCT04912765	Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC	recruiting	Phase 2	60	National Cancer Centre, SingaporeOTHER	1	Jul 31, 2026	clinicaltrials